Publication:
Effectiveness and cost-effectiveness of a multicomponent intervention to implement a clinical practice guideline for systemic lupus erythematosus: protocol for a cluster-randomized controlled trial

dc.contributor.authorTrujillo-Martín, María M
dc.contributor.authorRamallo-Fariña, Yolanda
dc.contributor.authorDel Pino-Sedeño, Tasmania
dc.contributor.authorRúa-Figueroa, Íñigo
dc.contributor.authorTrujillo-Martín, Elisa
dc.contributor.authorVallejo-Torres, Laura
dc.contributor.authorImaz-Iglesia, Iñaki
dc.contributor.authorSánchez-de-Madariaga, Ricardo
dc.contributor.authorde Pascual y Medina, Ana María
dc.contributor.authorSerrano-Aguilar, Pedro
dc.contributor.authorSLE-CPG-Implementation Group
dc.contributor.funderInstituto de Salud Carlos III
dc.date.accessioned2020-02-14T11:46:18Z
dc.date.available2020-02-14T11:46:18Z
dc.date.issued2019-11-01
dc.description.abstractBACKGROUND: Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease with significant potential morbidity and mortality. Substantial gaps have been documented between the development and dissemination of clinical practice guidelines (CPG) and their implementation in practice. The aim of this study is to assess the effectiveness and cost-effectiveness of a multi-component knowledge transfer intervention to implement a CPG for the management of SLE (CPG-SLE). METHODS: The study is an open, multicentre, controlled trial with random allocation by clusters to intervention or control. Clusters are four public university hospitals of the Canary Islands Health Service where rheumatologists are invited to participate. Patients diagnosed with SLE at least one year prior to recruitment are selected. Rheumatologists in intervention group receive a short educational group programme to both update their knowledge about SLE management according to CPG-SLE recommendations and to acquire knowledge and training on use of the patient-centred approach, a decision support tool embedded in the electronic clinical record and a quarterly feedback report containing information on management of SLE patients. Primary endpoint is change in self-perceived disease activity. Secondary endpoints are adherence of professionals to CPG-SLE recommendations, health-related quality of life, patient perception of their participation in decision making, attitudes of professionals towards shared decision making, knowledge of professionals about SLE and use of healthcare resources. Calculated sample size is 412 patients. Data will be collected from questionnaires and clinical records. Length of follow-up will be 18 months. Multilevel mixed models with repeated time measurements will be used to analyze changes in outcomes over time. Cost-effectiveness, from both social and healthcare services perspectives, will be analyzed by measuring effectiveness in terms of quality-adjusted life years gained. Deterministic and probabilistic sensitivity analyses are planned. DISCUSSION: Impact of CPGs in clinical practice could be improved by applying proven value interventions to implement them. The results of this ongoing trial are expected to generate important scientifically valid and reproducible information not only on clinical effectiveness but also on cost-effectiveness of a multi-component intervention for implementation of a CPG based on communication technologies for chronic patients in the hospital setting. TRIAL REGISTRATION: ClinicalTrial.gov NCT03537638 . Registered on 25 May 2018.es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipThis study is funded by the Carlos III Health Institute, a Spanish public health research institute (Grant number: PI12/01348). This institution has no further role in the study design, collection, analysis and interpretation of data, drawing up of the manuscript or the decision to submit the paper for publication.es_ES
dc.format.number1es_ES
dc.format.page783es_ES
dc.format.volume19es_ES
dc.identifier.citationBMC Health Serv Res. 2019 Nov 1;19(1):783.es_ES
dc.identifier.doi10.1186/s12913-019-4589-9es_ES
dc.identifier.e-issn1472-6963es_ES
dc.identifier.issn1472-6963es_ES
dc.identifier.journalBMC health services researches_ES
dc.identifier.pubmedID31675957es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/9092
dc.language.isoenges_ES
dc.publisherBioMed Central (BMC)es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PI12/01348es_ES
dc.relation.publisherversionhttps://doi.org/10.1186/s12913-019-4589-9es_ES
dc.repisalud.centroISCIII::Agencia de Evaluación de Tecnologías Sanitariases_ES
dc.repisalud.centroISCIII::Unidad de Investigación en Telemedicina y eSaludes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectCare managementes_ES
dc.subjectClinical practice guidelinees_ES
dc.subjectCost-effectivenesses_ES
dc.subjectDecision support aidses_ES
dc.subjectElectronic communicationes_ES
dc.subjectImplementationes_ES
dc.subjectKnowledge transferes_ES
dc.subjectMulticomponent interventiones_ES
dc.subjectSecondary carees_ES
dc.subjectSystemic lupus erythematosuses_ES
dc.titleEffectiveness and cost-effectiveness of a multicomponent intervention to implement a clinical practice guideline for systemic lupus erythematosus: protocol for a cluster-randomized controlled triales_ES
dc.typeresearch articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublicationb21a9249-53ef-4cd6-b700-56908ef9fa77
relation.isAuthorOfPublicationef1f86bf-f242-486b-824a-f72079a729b2
relation.isAuthorOfPublication8468deff-9cfb-4ed7-beaf-563ee66302bb
relation.isAuthorOfPublication.latestForDiscoveryb21a9249-53ef-4cd6-b700-56908ef9fa77

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
EffectivenessAndCostEffectiveness_2019.pdf
Size:
656.06 KB
Format:
Adobe Portable Document Format
Description: